Rapid inhalation induction (RII) was
L ~nduction rapide par inhalation (IIR) a dtd utilisde avec succ~s chez des patients non myasthdniques. On peut administrer des inhalatoires pour linduction de l'anesthdsie chez le myasthdnique et dviter ainsi d'utiliser des myordsolutifs. Nous avons compard l'llR chez 15 myasthdniques (MG) et 15 sujets normaux (nMG). Nous avons mesurd le temps d~nduction (TI), le retentissement cardiovasculaire, les complications et la rdaction du patient ~ ce type d~nduction. Les MG ont subi une thymectomie programmde trans-sternale et les nMG une chirurgie programm~e abdominale basse ou gyndcologique. Aucun des patients n'a re~u de prdmddication. Aprds prdoxygdnation, I'IIR est initi~e avec un mdlange d'halothane 4% et de 02:N20 (1:2). Les patients ont exdcut~ trois capacitds vitales et
Of the anaesthetic induction options available for myasthenic patients, a technique using only inhalational agents provides muscle relaxation and avoids complications associated with the use of neuromuscular blocking drugs in these patients. 1,2 It may also produce adequate anaesthesia depth for tracheal intubation.
Anticholinesterase treatment may complicate the anaesthetic management of myasthenics, and may increase CAN J ANAESTH 1994 / 41:2 / pp 102-6 vagal responses. 2-5 From our experience of 132 myasthenic patients anaesthetized since 1983, we have observed that when we have used a classical inhalational anaesthetic induction technique, increasing the anaesthetic concentration gradually, it may take longer than ten minutes to produce anaesthesia of sufficient depth to allow tracheal intubation. Similar observations have been described by others. 6 A rapid inhalational induction (RII) technique using 4% halothane, with or without nitrous oxide, has been described as safe, rapid and useful for patients without myopathy. 7-12 Our aim was to compare the use of RII in myasthenic patients with that in normal subjects by evaluating the anaesthesia induction time, the effects on the cardiorespiratory system and the incidence of undesirable effects.
Methods
After institutional Ethics Committee approval and patients' informed consent 30 adult subjects were studied, 15 myasthenic -myasthenic group (MG), and 15 non myasthenic patients -non myasthenic group (nMG). Sex distribution for MG was six males and nine females and for nMG was one and 14 respectively. They were scheduled to undergo elective thymectomy (MG) gynaecological or lower abdominal surgery (nMG).
Myasthenics were classified as Osserman's class IIA or liB. ~3 Six were class IIA myasthenics presenting with generalized mild muscle weakness and the remaining nine were class liB complaining of generalized moderate weakness, and/or bulbar disfunction. All were receiving oral pyridostigmine (four patients, 240 mg per day; nine, 180 mg per day and two, 120 mg per day). Ten were receiving oral prednisone (six were taking 80 mg and four, 40 mg per day). Anticholinesterase and steroid drugs were withdrawn on the morning of surgery. Preoperative spirometry and arterial blood gas analysis were normal for all myasthenics. Patients of the nMG group were free of pulmonary disease and had normal thorax x-rays. No premeditation was used, and no patient was receiving other medication. Before induction of anaesthesia, myasthenic patients received bolus hydrocortisone/v equivalent to the withdrawn oral morning steroid dose.
The induction technique was explained during the preanaesthetic visit. Before induction, all patients received preoxygen for three minutes with an O2 flow of I0 L. min-l using a separate circuit. Meanwhile, the circle system of the anaesthesia machine was saturated with an 8 L. min -I flow of 4% halothane, and O2-N20 (1:2) mixture. Rapid inhalation induction was started by asking the patient to perform three vital capacity breaths (VCB), inhaling the anaesthetic mixture from the circle circuit through a well-fitted facial mask. 7-12 69 (17) 73 (27) Mean values (SD).
Respiratory rate (RR), heart rate (HR), non-invasive systolic (SBP) and diastolic blood pressure (DBP), pulse oximetry (SpO2, Novametrix 550) and capnometry (PETCO2, Novametrix 1260) were measured before (except for PETCO2) and during induction, every minute, for four minutes. Induction time (TI) was assessed by measuring the time from the f~t of the three VCB, and the loss of response to verbal command (TLVC) and the loss of the eyelid reflex (TLER). The TLVC was evaluated by asking patients to open their eyes. The TLVC and TLER were assessed every ten seconds throughout the anaesthetic induction. At the same time, undesirable reactions, such as cough or airway obstruction, and the cardiorespiratory variables were recorded during the four minutes. After the fourth minute, the halothane concentration was decreased to 2%. The induction was completed by manual ventilation and the trachea was intubated after clinical assessment of jaw muscle relaxation. Anaesthesia was maintained with halothane, nitrous oxide and oxygen. On the day after surgery the patients answered an objective questionnaire to determine (1) how many of the three VCB they could remember; (2) the patients' evaluation of the anaesthetic induction; and (3) if the patients would accept the RII technique again. Data were analysed using ANOVA associated with NewmanKeuls test to compare, within each group, the cardiorespiratory variables obtained before RII with those recorded one, two, three and four minutes after RII. Unpaired t test and Fisher's exact test were used to compare parametric and non-parametric data, respectively.
Results
The mean values (SD) for age and weight were similar in both groups: 31.1.(7.1) yr and 54.9 (7.7) kg for nMG group, and 34.8 (l l) yr and 63 (23.2) kg for MG group.
There were no differences in induction times between groups (Table I) .
Haemodynamic variables
Non-myasthenics demonstrated a decrease in diastolic pressure at all four measurement times and a decrease in systolic pressure at three and four minutes. Heart rate increased at one and two minutes (Table II and Figure  1 ). Myasthenics showed a decrease of systolic pressure FIGURE 1 Haemodynamic and respiratory data befre and during RII for nMG patients. Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), respiratory rate (RR), and end tidal CO 2 (PETCO2). *P < 0.05 and **P < 0.01 compared with before
RI1.
at three and four minutes of the study (Fable III and Figure 2 ). No changes in heart rate were observed in myasthenics.
Respiratory variables
SpO2 decreased in both groups at three and four minutes, although always remaining >97% (Tables IV and V) . No changes in PETCO2 were recorded in boa groups (Tables IV and V) . RR increased at three and four minutes for nMG and at two, three and four minutes for MG (Tables IV and V ; Figures 1 and 2 ). During the study five myasthenic and three nonmyasthenic patients developed airway obstruction which required the use of a Guedel oropharyngeal airway. Coughing was observed in two myasthertic and in one non-myasthenie. In five patients (three myasthenic) apnoea (> 15 sec without respiratory movements) was ob- FIGURE 2 Haemodynamic and respiratory data before and during RII for MG patients. Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), respiratory rate (RR), and end tidal CO 2 (PETCO2). **P< 0.01. served. Excitatory movements of the extremities occurred in five myasthenic and in four non-myasthenic patients. None of these undesirable reactions precluded the completion of anaesthetic induction or of tracheal intubation. One myasthenic patient developed ventricular extrasystoles which reverted spontaneously to sinusal rhythm. This occurred after the fourth minute of the study, when halothane 2% was being used. All tracheal intubations were performed without difficulty, within five minutes after the fourth minute of the study. In all patients the trachea was extubated at the end of the procedure. The number of remembered VCB is shown in Table  VI . The median of the remembered inspirations was two in both groups. All myasthenics classified the anaesthetic technique as good and they would not oppose its use again. Twelve non-myasthenic patients classified RII as good, and three as bad. Of the latter, two would oppose its use again. No laryngotracheal complication was recorded at the post-anaesthetic visit.
Discussion
Unpredictable response to muscle relaxants administration is well recognized in patients with myasthenia gravis. Although atracurium has been used in m gray/s, there is an absolute indication for careful neuromuscular transmission monitoring during surgery to titrate the dose of the neuromuscular blocking agent. 2 Baraka has described the use of a deep inhalation anaesthesia technique either for tracheal intubation or for the anaesthetic maintenance of myasthenics. 2 A rapid inhalation induction anaesthetic technique was successfully described in subjects without neuromuscular disease. Two techniques of RII have been described, using one or three VCBs. They produced a deep level of anaesthesia rapidly for tracheal intubation, avoiding the unpleasant experience of inhaling increasingly higher concentrations of volatile agents. 7-~2 We chose the three VCB method because it seemed to produce a more rapid induction. 9 The analysis of the anaesthetic induction times (TLVC and TLER) indicates that the myasthenic patients reached a similar anaesthetic depth in a similar time as normal subjects. Both groups presented values of TLVC ad TLER similar to studies when RII was used in patients without myopathy. 7-. When the classical inhalation technique was performed previously in myasthenics, using enflurane at increasing concentrations, the effects on heart rate and arterial blood pressure were almost negligible, and the observed period for anaesthesia induction, ranged from five to ten minutes. 6 Both groups presented similar behaviour in respect to circulatory and respiratory variables. The RII provoked similar haemodynamic changes in both groups. The observed tendency towards a decrease in arterial blood pressure, although rendering normal mean values of blood pressure, is an expected side effect of halothane. Heart rate did not decrease in either group.
Florence et al. found when studying the effects of two intravenous anaesthetic drugs in myasthenic patients, that patients developed 54.6% of transient bradycardia. Approximately 30% of their patients presented arterial hypotension, s They stated that bradycardia and arterial hypotension were expected, as a low resting heart rate is common in myasthenic patients as a result of residual muscafinl"c action of the chronic anticholinesterase therapy. From our circulatory findings in the myasthenic group we suggest that, despite using high concentrations of anaesthetic agent, we did not find an interaction between halothane and chronic anticholinesterase therapy.
In both groups RR increased, but SaO2 and PETCO2 were within the normal range showing that gas exchange was not affected during the RII.
We do not consider the use of 4% halothane a hindrance for the use of the technique. In both groups, the median of the vital capacity breaths remembered while such a percentage was being used, was two. This is very close to the three VCB required by the technique. 9 Even with this high index of recall in patients in the high halothane concentration group, only 6.7% of patients (2 of 30) would oppose the use of RII to induce anaesthesia if necessary. Both patients were from the nMG group. Myasthenic patients often consider thymectomy as the last chance for their cure. From this point of view, they could be more prone to accept the whole procedure, anaesthesia included, than the nMG patients.
Chronic anticholinesterase therapy can be associated with increase in salivary and bronchial secretion. 2-4 This could predispose to a larger incidence of cough or airway irritation during inhalatory technique. However, we observed no difference regarding these complications when we compared both groups.
Although both groups had a similar incidence of complications, in three myasthenic patients we found difficulty in the maintenance of the airway throughout the induction. All three were moderately obese and presented with cough and airway obstruction. Obesity can make the management of the airway difficult, imposing an obstacle to the establishment of a rapid and adequate depth of anaesthesia.
Halothane has a variable effect on the neuromuscular activity in MG patients. About one third of the MG patients presented no sign of muscular fading induced by halothane-N20 anaesthesia. 14 For this reason, the speed of inducing muscle relaxation invariably in myasthenic patients is considered.
Recently sevoflurane has proved to be superior to halothane when RII was used in normal patients. 12 The onset is faster and less irritating than halothane and this may be another option for RII of patients with m. gravis.
In summary, we used the RII safely in myasthenic subjects for thymectomy, to avoid the risk of neuromuscular blocking agents. We did not find cardiorespiratory effects or pharmacological interaction between halothane and anticholinesterase therapy. The time for losing conscienceness was within acceptable range. We believe that RII can be a technique to be considered for anaesthetic induction in myasthenic patients.
